ResearcherUniversity of Colorado AnschutzActive in the last 2 years
Andrii Khomiak
Matched on ORCID iD 0000-0003-0974-4965; OpenAlex author ID A5088097483. Sources: OpenAlex.
Their work
- Papers
- 5
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 3 papers
Papers 5
- Incidence and consequences of chyle leak after pancreatectomy for pancreatic cancer. Co-author DOI 10.1016/j.hpb.2025.10.004↗
- Neoadjuvant Therapy for Invasive Intraductal Papillary Mucinous Neoplasms: A Comparative Study With Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1245/s10434-025-18426-y↗
- ASO Visual Abstract: Neoadjuvant Therapy for Invasive Intraductal Papillary Mucinous Neoplasms: a Comparative Study with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1245/s10434-025-18603-z↗
- Oligometastatic pancreatic cancer: current state of management and emerging therapies. Co-author DOI 10.1093/oncolo/oyaf154↗
- Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer. Co-author DOI 10.3390/cancers12113234↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Marco Del Chiaro · 3 shared papers, 2025–2026 · strength 0.86
- Paper Neoadjuvant Therapy for Invasive Intraductal Papillary Mucinous Neoplasms: A Comparative Study With Pancreatic Ductal A… DOI 10.1245/s10434-025-18426-y↗
- Paper ASO Visual Abstract: Neoadjuvant Therapy for Invasive Intraductal Papillary Mucinous Neoplasms: a Comparative Study wit… DOI 10.1245/s10434-025-18603-z↗
- Paper Oligometastatic pancreatic cancer: current state of management and emerging therapies. DOI 10.1093/oncolo/oyaf154↗
- Oskar Franklin · 3 shared papers, 2026 · strength 0.86
- Paper Neoadjuvant Therapy for Invasive Intraductal Papillary Mucinous Neoplasms: A Comparative Study With Pancreatic Ductal A… DOI 10.1245/s10434-025-18426-y↗
- Paper ASO Visual Abstract: Neoadjuvant Therapy for Invasive Intraductal Papillary Mucinous Neoplasms: a Comparative Study wit… DOI 10.1245/s10434-025-18603-z↗
- Paper Incidence and consequences of chyle leak after pancreatectomy for pancreatic cancer. DOI 10.1016/j.hpb.2025.10.004↗
- Hiroyuki Ishida · 3 shared papers, 2026 · strength 0.86
- Paper Neoadjuvant Therapy for Invasive Intraductal Papillary Mucinous Neoplasms: A Comparative Study With Pancreatic Ductal A… DOI 10.1245/s10434-025-18426-y↗
- Paper ASO Visual Abstract: Neoadjuvant Therapy for Invasive Intraductal Papillary Mucinous Neoplasms: a Comparative Study wit… DOI 10.1245/s10434-025-18603-z↗
- Paper Incidence and consequences of chyle leak after pancreatectomy for pancreatic cancer. DOI 10.1016/j.hpb.2025.10.004↗
- Richard David Schulick · 3 shared papers, 2026 · strength 0.86
- Paper Neoadjuvant Therapy for Invasive Intraductal Papillary Mucinous Neoplasms: A Comparative Study With Pancreatic Ductal A… DOI 10.1245/s10434-025-18426-y↗
- Paper ASO Visual Abstract: Neoadjuvant Therapy for Invasive Intraductal Papillary Mucinous Neoplasms: a Comparative Study wit… DOI 10.1245/s10434-025-18603-z↗
- Paper Incidence and consequences of chyle leak after pancreatectomy for pancreatic cancer. DOI 10.1016/j.hpb.2025.10.004↗
- Yuki Fujiwara · 2 shared papers, 2026 · strength 0.58
- Paper Neoadjuvant Therapy for Invasive Intraductal Papillary Mucinous Neoplasms: A Comparative Study With Pancreatic Ductal A… DOI 10.1245/s10434-025-18426-y↗
- Paper ASO Visual Abstract: Neoadjuvant Therapy for Invasive Intraductal Papillary Mucinous Neoplasms: a Comparative Study wit… DOI 10.1245/s10434-025-18603-z↗
- Christopher Hanyoung Lieu · 1 shared paper, 2025 · strength 0.28
- Robert William Lentz · 1 shared paper, 2025 · strength 0.28
- Wells A. Messersmith · 1 shared paper, 2025 · strength 0.28
- Toshitaka Sugawara · 1 shared paper, 2026 · strength 0.28
- Jun Ishida · 1 shared paper, 2026 · strength 0.28
- Marco Del Chiaro · 1 shared paper, 2026 · strength 0.28
- Samuele Grandi · 1 shared paper, 2026 · strength 0.28
- Thomas F. Stoop · 1 shared paper, 2026 · strength 0.28
- Rainer Christoph Miksch · 1 shared paper, 2020 · strength 0.13
- Ivonne Regel · 1 shared paper, 2020 · strength 0.13
- Maximilian Kordes · 1 shared paper, 2020 · strength 0.13
- Daniel Öhlund · 1 shared paper, 2020 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.